Correlation Between Acumen Pharmaceuticals and Telus Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and Telus Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and Telus Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and Telus Corp, you can compare the effects of market volatilities on Acumen Pharmaceuticals and Telus Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of Telus Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and Telus Corp.

Diversification Opportunities for Acumen Pharmaceuticals and Telus Corp

-0.24
  Correlation Coefficient

Very good diversification

The 3 months correlation between Acumen and Telus is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and Telus Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telus Corp and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with Telus Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telus Corp has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and Telus Corp go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and Telus Corp

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to generate 4.49 times more return on investment than Telus Corp. However, Acumen Pharmaceuticals is 4.49 times more volatile than Telus Corp. It trades about 0.01 of its potential returns per unit of risk. Telus Corp is currently generating about -0.03 per unit of risk. If you would invest  272.00  in Acumen Pharmaceuticals on September 4, 2024 and sell it today you would lose (37.00) from holding Acumen Pharmaceuticals or give up 13.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Acumen Pharmaceuticals  vs.  Telus Corp

 Performance 
       Timeline  
Acumen Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Acumen Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Acumen Pharmaceuticals is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Telus Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Telus Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Telus Corp is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Acumen Pharmaceuticals and Telus Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acumen Pharmaceuticals and Telus Corp

The main advantage of trading using opposite Acumen Pharmaceuticals and Telus Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, Telus Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telus Corp will offset losses from the drop in Telus Corp's long position.
The idea behind Acumen Pharmaceuticals and Telus Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world